Treatment response amplitude and timing in chronic inflammatory demyelinating polyneuropathy with routine care: Study of a UK cohort

Documenti analoghi

• Determinants of long‐term disability in chronic inflammatory demyelinating polyradiculoneuropathy: A multicenter Korea/UK study of 144 patients
  di: Young Gi Min, et al.
  Pubblicazione: (2024)
• Serum glycobiomarkers for chronic inflammatory demyelinating polyneuropathy
  di: Soma Furukawa, et al.
  Pubblicazione: (2024)
• A study on the role of serum uric acid in differentiating acute inflammatory demyelinating polyneuropathy from acute‐onset chronic inflammatory demyelinating polyneuropathy
  di: Weiyun Zhang, et al.
  Pubblicazione: (2024)
• Very High Dose Immunoglobulin Treatment for Chronic Inflammatory Demyelinating Polyneuropathy: A Multicentre UK Study
  di: Yusuf A. Rajabally, et al.
  Pubblicazione: (2025)
• Association of the neonatal Fc receptor promoter variable number of tandem repeat polymorphism with immunoglobulin response in patients with chronic inflammatory demyelinating polyneuropathy
  di: Anna Lena Fisse, et al.
  Pubblicazione: (2024)